| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787619 | Journal of Thoracic Oncology | 2018 | 29 Pages |
Abstract
Our findings suggest that PCI in patients with extensive stage small cell lung cancer may lead to a significant benefit in 1-year survival, progression-free survival, and the risk of brain metastasis, despite the lack of a significant advantage in OS.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Chi Hoon MD, PhD, Jae-Uk MD, PhD, Sung Ryul PhD, Jonghoo MD, PhD,